Primitive neuroectodermal tumor (PNET) of the lung in an adult woman

Primitive neuroectodermal tumors (PNETs) are small-blue-round-cell malignancies, predominantly arising in the soft tissues or bones in children and young adults [1]. PNETs belong to the Ewing’s sarcoma family of tumors, based on shared chromosomal translocation at EWSR1 (Ewing sarcoma breakpoint region 1). Primary PNETs of the lung are extremely rare, with fewer than 20 cases having been described in English literature to date. Most of these are adolescent or young adult patients, with a male predominance [2‐13]. In this case report, we describe a PNET of lung in an adult woman, having a rapid progression of the disease and lethal outcome.

A 31-year-old woman presented with a 10-month history of right hemithoracic pain and persistent cough, with relative improvement during the day and relative worsening at night. She also reported a weight loss of approximately 11 kg. Computed tomography (CT) and positron emission tomography (PET) imaging of the thorax revealed non-homogeneous opacities and increased accumulation of glucose in the right pleural cavity. Right pleural deposits, found during examination, suggested the presence of viable tumor masses. Directed transparietal biopsy, taken from the glucose accumulation sites seen on the PET scan, was performed.Histopathological examination of the biopsy specimens revealed highly cellular neoplastic tissue. The tumor cells were discohesive, showed scant basophilic cytoplasm, and ovoid rather than polygonal nuclei, fine granular chromatin texture, and marked nucleoli. Some of the nuclei were hyperchromatic. There were no evidence of mitotic or apoptotic activity. No obvious signs of necrosis were present, and the stromal tissue adjacent to the tumor was characterized by low cellularity. In some areas, small Homer-Wright rosette-like structures were present. Overall, morphological characteristics were consistent with small-blue-round-cell neoplasm (Figure 1a, b ,c).

A range of immunohistochemical markers were employed for final diagnosis (Table 1), including CD4, CD8, CD10, CD15, CD20, CD34, leukocyte common antigen (CD45), CD56, CD99, cytokeratin 7 (CK7), vimentin, thyroid transcription factor (TTF), synaptophysin, chromogranin, anti-cytokeratin cocktail, High Molecular weight cytokeratin,, calretinin, h-caldesmon, smooth muscle actin (SMA) and mesothelial cell marker (antibody clone: HBME-1). Detailed characteristics and dilutions of antibodies are provided in Additional file 1: Table S1. Immunohistochemical study showed Strong positivity for CD99 (Figure 1d). The neoplastic cells were also focally positive for CD56 and weekly positive for Vimentin (Figure 1e, f). Expression of TTF was extremely weak. All other markers were negative. Proliferative activity, detected by Ki-67 index, was estimated as 5 to 10%. Immunophenotype was characteristic for PNET of the lung.

Chromosome rearrangement in the EWSR1 gene was detected by fluorescent in situ hybridization assay (FISH) to confirm the diagnosis. The results of FISH analysis showed translocation of EWSR1 in 30% of the tumor cells (Figure 1g, h). More detailed description of molecular analysis in provided in Additional file 1: S2.

Diagnosis was followed by two series of chemotherapy (doxorubicin, cyclophosphamide and vincristine) for 2 days. After 1 month, secondary anemia developed. The patient was treated with hemosubstitution, but her health deteriorated and she died. Post-mortem examination revealed a tumor in the right lung, 210 × 115 × 60 mm in size. The cut surface of the tumor was pinkish colored and areas of hemorrhage were present. Post-mortem and subsequent histopathological examination showed generalized PNET, (Additional file 1: Figure S1), with tumor spread to the mediastinal lymph nodes and subhepatic area. Acute catarrhal purulent bronchopneumonia was present in the left lung. The cause of death was given as cardiorespiratory failure.

PNETs are highly aggressive, usually lethal neoplasms. Although the morphological and immunohistochemical features of pulmonary PNET are not different from its counterparts of other origin, special diagnostic considerations of other tumors with small, blue, round cell morphology and primarily small cell carcinoma of the lung is necessary. Small cell carcinomas usually present at older ages, and usually with a history of smoking, yet they and PNET may exhibit similar histological features. Some PNETs may even show reactivity for cytokeratin and synaptophysin [11, 12]. Hence, a wider range of immunohistochemical markers, including chromogranin and TTF-1 to support a diagnosis of small cell carcinoma, and CD99, vimentin, or FLI1 for PNET should be used for the differential diagnosis. Lung carcinoids share a similar morphology to PNET and form rosettes. However, the detection of chromogranin, synaphtopysin, and neuron specific enolase is necessary to confirm the diagnosis of lung carcinoid. In addition, differential diagnosis is necessary to distinguish PNET from metastasis of small cell carcinomas of other origin. Another important diagnostic consideration for both children and adult patients is pulmonary rhabdomyosarcoma, which is also a rare tumor and belongs to the group of small,-blue,-round-cell tumors. Muscle-specific markers such as desmin, myogenin, or myo-D1, characteristic of rhabdomyosarcoma, should be included in the immunohistochemical study [10]. Lymphoblastic lymphoma and the leukemia group of tumors are also an important diagnostic consideration, as they can be positive for CD99 and negative for epithelial markers. Precursor B-cell lymphoblastic lymphoma is an especially important mimicker of PNET. Like PNET, the malignant cells are small and uniform and have a diffusely infiltrative growth pattern, and they can even form rosette-like structures. Immunohistochemically, precursor B-cell lymphoblastic lymphoma is positive for CD99, and often nonreactive or only focally positive for conventional lymphoma markers such as LCA, CD20, and CD3. Immunopositivity for CD45, CD43, and CD79a are useful for separating lymphoblastic lymphoma/leukemia from PNET [14]. Finally, to confirm the diagnosis of PNET, it is crucial to detect pass break or amplification of EWSR1[15]. However, because of the rarity of primary pulmonary PNETs, it is also important to exclude the possibility of metastasis from a bone or soft tissue primary to the lung. Detailed examination by clinical and radiological means should be performed to rule out metastatic tumor from an extrapulmonary primary site.

Oral informed consent was obtained from the responsible person for publication of this Case report and any accompanying images.